PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,386,000 | +11.1% | 307,547 | +2.1% | 0.00% | 0.0% |
Q1 2020 | $2,147,000 | -70.0% | 301,175 | +0.6% | 0.00% | -66.7% |
Q4 2019 | $7,149,000 | -11.9% | 299,391 | -1.0% | 0.00% | 0.0% |
Q3 2019 | $8,113,000 | +16.9% | 302,501 | +18.2% | 0.00% | 0.0% |
Q2 2019 | $6,941,000 | +1080.4% | 255,839 | +2018.0% | 0.00% | -25.0% |
Q4 2017 | $588,000 | – | 12,079 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 270,832 | $6,467,000 | 5.27% |
Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |